logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover
ARWR
Arrowhead Pharmaceuticals, Inc.
66.48
2 x 61.58
2 x 72.52
bid
ask
-
1.26
1.86%
2 @ 04:01 AM
67.68 +1.20 (1.81%)
Ytd0.14%
1y110.98%
66.36
day range
68.00
30.70
52 week range
95.49
Open67.83Prev Close67.74Low66.36High68.00Mkt Cap9.39B
Vol4.02MAvg Vol2.16MEPS-2.28P/EN/AForward P/E-13.84
Beta1.28Short Ratio8.12Inst. Own85.53%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-2450-d Avg82.73200-d Avg72.481yr Est110.00

ARWR News

Arrowhead Pharmaceuticals Spotlights Dual-Target RNAi Data, Plozasiran Launch Progress
marketbeat.com
Arrowhead Pharmaceuticals Spotlights Dual-Target RNAi Data, Plozasiran Launch Progress

Arrowhead Pharmaceuticals NASDAQ: ARWR executives outlined early clinical data for its RNA interfere

Arrowhead Pharmaceuticals Eyes SHTG Filing as RNAi Pipeline Expands
marketbeat.com
Arrowhead Pharmaceuticals Eyes SHTG Filing as RNAi Pipeline Expands

Arrowhead Pharmaceuticals NASDAQ: ARWR is expanding its commercial and clinical footprint around RNA

10 Health Care Stocks Whale Activity In Today’s Session
benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript
seekingalpha.com
Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at H.C. Wainwright 28th Annual Global Investment Con

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at H.C. Wainwright 28th Annual Global Investment Con

Arrowhead Achieves Clinical Validation for New Drug Platform
benzinga.com
Arrowhead Achieves Clinical Validation for New Drug Platform

Arrowhead Pharmaceuticals reports interim Phase 1/2a data for ARO-DIMER-PA, demonstrating dual-gene

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com
Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 24th Annual Global Healthcare Conf

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 24th Annual Global Healthcare Conf

10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
benzinga.com
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

The 10-year Treasury yield broke 5% for the first time since 2007 as WTI surged past $105 on Saudi p

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
gurufocus.com
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi

[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced interim topline data fro

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
businesswire.com
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced in
benzinga.com
Citigroup Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $108

Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rat
benzinga.com
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $120 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) wit
benzinga.com
RBC Capital Reiterates Outperform on Arrowhead Pharma, Maintains $100 Price Target

RBC Capital analyst Luca Issi reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and mai
benzinga.com
Reported Earlier, Arrowhead Reports Plozasiran Also Reduced Pancreatitis Risk In Severe Triglyceride

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today presented results from the pivotal Phase 3 SHAST
benzinga.com
Arrowhead Pharmaceuticals To Present Data On Plozasiran In Patients With Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it will present important new dat